News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Press Releases

Epigenomics AG: Securities prospectus for the issuance of a mandatory convertible bond in the amount of up to EUR 16.5 million approved by BaFin

DGAP-News: Epigenomics AG / Key word(s): Issue of Debt/Corporate Action24.08.2021 / 16:16 The issuer is solely responsible for the content of this announcement. NOT TO BE PUBLISHED, DISSEMINATED OR PASSED ON TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA AND SOUTH AFRICA Press Release / Advertising Epigenomics AG: Securities prospectus for the […]

Read more

​​​​​​​Epigenomics AG Reports Financial Results for the First Six Months of 2021

DGAP-News: Epigenomics AG / Key word(s): Half Year Report/Half Year Results11.08.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Six Months of 2021 Berlin (Germany) and San Diego, CA (U.S.A.), August 11, 2021 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the “Company”) […]

Read more

Epigenomics AG Reports Financial Results for the First Quarter of 2021

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results12.05.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Reports Financial Results for the First Quarter of 2021 Berlin (Germany) and San Diego, CA (U.S.A.), May 12, 2021 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the […]

Read more

Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders

DGAP-News: Epigenomics AG / Key word(s): Capital Increase27.04.2021 / 17:40 The issuer is solely responsible for the content of this announcement. NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA AND SOUTH AFRICA. Press release Epigenomics AG decides to increase share capital through rights […]

Read more

​​​​​​​Epigenomics AG announces conversion result of the first conversion period of the mandatory convertible bond 2021/2024

DGAP-News: Epigenomics AG / Key word(s): Bond/Miscellaneous20.04.2021 / 15:39 The issuer is solely responsible for the content of this announcement. Epigenomics AG announces conversion result of the first conversion period of the mandatory convertible bond 2021/2024  Berlin (Germany) and San Diego (U.S.A.), April 20, 2021 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the […]

Read more

Study reported in BMC Gastroenterology shows significantly better performance characteristics of Epigenomics’ liver cancer panel compared to the current standard of care for the early detection of HCC

DGAP-News: Epigenomics AG / Key word(s): Study results/Study06.04.2021 / 07:59 The issuer is solely responsible for the content of this announcement. Study reported in BMC Gastroenterology demonstrates significantly better performance characteristics of Epigenomics’ liver cancer panel compared to the current standard of care for the early detection of hepatocellular carcinoma (HCC) in patients with liver […]

Read more